Trademark: 86705282
Word
VUZALPEX
Status
Dead
Status Code
604
Status Date
Friday, May 27, 2016
Serial Number
86705282
Mark Type
4000
Filing Date
Monday, July 27, 2015
Published for Opposition
Tuesday, February 9, 2016
Abandoned Date
Friday, May 27, 2016

Trademark Owner History
Glaxo Group Limited - Owner At Publication

Classifications
5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Trademark Events
May 27, 2016
Abandonment Notice Mailed - Inter Partes Decision
May 27, 2016
Abandonment - After Inter Partes Decision
May 27, 2016
Opposition Terminated No. 999999
May 27, 2016
Opposition Sustained No. 999999
Mar 10, 2016
Opposition Instituted No. 999999
Mar 10, 2016
Opposition Papers Received At Ttab
Feb 9, 2016
Official Gazette Publication Confirmation E-Mailed
Feb 9, 2016
Published For Opposition
Jan 20, 2016
Notification Of Notice Of Publication E-Mailed
Nov 5, 2015
Approved For Pub - Principal Register
Nov 5, 2015
Examiner's Amendment Entered
Nov 5, 2015
Notification Of Examiners Amendment E-Mailed
Nov 5, 2015
Examiners Amendment E-Mailed
Nov 5, 2015
Examiners Amendment -Written
Nov 4, 2015
Assigned To Examiner
Jul 31, 2015
New Application Office Supplied Data Entered In Tram
Jul 31, 2015
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24